KemPharm

-$0.20 (-2.15%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KemPharm and other ETFs, options, and stocks.

About KMPH

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy.

CEO
Travis C. Mickle
Employees
22
Headquarters
Celebration, Florida
Founded
2006

KMPH Key Statistics

Market Cap
319.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
487.15K
High Today
$9.37
Low Today
$9.05
Open Price
$9.27
Volume
297.92K
52 Week High
$18.15
52 Week Low
$5.86

KMPH Earnings

-$1.61
-$1.00
-$0.39
$0.22
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.22 per share
Actual
-$0.40 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure